| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 6.167 | 16.307 | 23.708 | 22.745 | 52.952 | - | 51.895 | 38.300 | 27.105 | 29.605 |
| Total Income - EUR | 8.416 | 16.307 | 23.708 | 22.745 | 52.952 | - | 51.895 | 38.300 | 27.105 | 29.605 |
| Total Expenses - EUR | 12.434 | 6.351 | 4.232 | 9.205 | 38.713 | - | 37.423 | 34.021 | 41.026 | 31.370 |
| Gross Profit/Loss - EUR | -4.017 | 9.956 | 19.475 | 13.540 | 14.239 | - | 14.472 | 4.279 | -13.921 | -1.765 |
| Net Profit/Loss - EUR | -4.270 | 9.467 | 18.764 | 12.857 | 12.651 | - | 12.946 | 3.272 | -14.159 | -2.653 |
| Employees | 1 | 1 | 1 | 1 | 1 | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Cabinet De Medicină Şi Terapii Complementare Celed
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | - | 544 | 4.887 | 3.518 | 2.332 |
| Current Assets | 3.121 | 3.128 | 22.130 | 34.257 | 46.737 | - | 20.559 | 21.554 | 10.043 | 13.529 |
| Inventories | 0 | 0 | 0 | 0 | 0 | - | 2.240 | 2.599 | 2.589 | 11.803 |
| Receivables | 936 | 0 | 1.642 | 1.612 | 2.360 | - | 3.052 | 3.468 | 3.466 | 0 |
| Cash | 2.185 | 3.128 | 20.488 | 32.645 | 44.377 | - | 15.266 | 15.487 | 3.987 | 1.726 |
| Shareholders Funds | -10.128 | -557 | 18.217 | 30.740 | 42.796 | - | 12.722 | 16.033 | 1.825 | -839 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | - | 40 | 41 | 40 | 40 |
| Debts | 13.249 | 3.685 | 3.913 | 3.517 | 3.942 | - | 8.381 | 10.408 | 11.736 | 16.700 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Cabinet De Medicină Şi Terapii Complementare Celedonis Srl